AccessPak for HIV PEP Expanded with Kaletra and Trastuzumab and Hyaluronidase
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Trastuzumab Injection (Intravenous)
- AccessPak for HIV PEP Expanded with Kaletra-Trastuzumab Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Trastuzumab-anns
- AccessPak for HIV PEP Expanded with Kaletra-Trastuzumab-dkst
- AccessPak for HIV PEP Expanded with Kaletra-Trastuzumab-dkst Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Trasylol
- Trastuzumab and Hyaluronidase-AccessPak for HIV PEP Expanded with Viracept
- Trastuzumab and Hyaluronidase-Accolate
- Trastuzumab and Hyaluronidase-Accretropin
- Trastuzumab and Hyaluronidase-Accucaine
- Trastuzumab and Hyaluronidase-AccuHist Drops
- Trastuzumab and Hyaluronidase-AccuHist PDX Drops